IP Library › Granted Patent US 12,383,670
Granted Patent B2
US 12,383,670 · App. 18/188,304 · Granted Aug 12, 2025

Instruments and methods for loading cells into implantable devices

Inventors: Chad Green (San Diego, CA); Laura Martinson (San Diego, CA); Erik Olson (San Diego, CA); Val Anthony Bellora (San Diego, CA); Leah Elliott (San Diego, CA); Richard Alexander Grant (San Diego, CA); Donald Koenig (San Diego, CA); Giacomo Strollo (San Diego, CA)
Assignee: ViaCyte, Inc.
A61M5/14276A61F2/022A61M5/142A61M37/0069B65B3/003A61M2209/045C12N5/0676
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,383,670
App. No.
18/188,304
Granted
Aug 12, 2025
Kind
B2
Abstract

Embodiments herein describe tools, instruments and methods for aseptic loading, dispensing and/or delivering cells into an implantable device and aseptically and selectively sealing a device inside a sterile package as well as and storing and preparing for shipment the cell-filled device.

Claims (26)

1. A cell loading system for transferring cells from a cell source to an implantable device, the loading system comprising:

a support for supporting the implantable device;

a dosing tube assembly comprising a dosing tube and a fluid reservoir tube fluidly connected to the dosing tube, wherein the dosing tube has an outlet end that is positionable in the cell source to draw cells from the cell source into the dosing tube assembly and then removed from the cell source and positioned in the implantable device to inject cells contained in the dosing tube assembly into the implantable device;

a syringe pump comprising a piston, a cylinder, and a motor configured to control displacement of the piston relative to the cylinder, wherein the syringe pump is fluidly connected to the fluid reservoir tube, wherein the syringe pump is operable to draw cells from the cell source into the dosing tube assembly under negative pressure when the outlet end of the dosing tube is in the cell source, and the syringe pump is further operable to pump cells contained in the dosing tube assembly into the implantable device under positive pressure when the outlet end of the dosing tube is in the implantable device;

wherein the fluid reservoir tube has a first end fluidly connected to the dosing tube, a second end fluidly connected to the syringe pump, and a portion between the first and second ends that is wound into a coil; and

a mounting surface, wherein the coil is supported on the mounting surface in a horizontal position.

2. The cell loading system of claim 1 , wherein the dosing tube assembly further comprises a fitting connecting the dosing tube to the fluid reservoir tube.

3. The cell loading system of claim 2 , further comprising a mount for holding the fitting and positioning the dosing tube relative to the cell source and the implantable device.

4. The cell loading system of claim 1 , wherein the height of the outlet end of the dosing tube relative to an interior of the cell source is adjustable when the outlet end of the dosing tube extends into the cell source.

5. The cell loading system of claim 1 , further comprising the implantable device, wherein the implantable device is a cell encapsulation device.

6. The cell loading system of claim 1 , further comprising the cell source, wherein cell source is a cell container, a cell reservoir, or a cell vial and cells stored therein.

7. The cell loading system of claim 6 , wherein the cells are pancreatic-type cells.

8. The cell loading system of claim 6 , wherein the cells are pancreatic progenitor cells, endocrine precursor cells, immature beta cells, or immature islet cells.

9. The cell loading system of claim 1 , a liquid pumping medium contained in the dosing tube assembly.

10. The cell loading system of claim 9 , wherein the liquid pumping medium comprises saline.

11. A cell loading system comprising:

an implantable device;

a cell source;

a dosing tube assembly comprising a dosing tube and a fluid reservoir tube fluidly connected to the dosing tube, wherein the dosing tube has an outlet end that can be inserted into and removed from the cell source and inserted into and removed from the implantable device;

a liquid pumping medium contained in the dosing tube assembly; and

a syringe pump comprising a piston, a cylinder, and a motor configured to control displacement of the piston relative to the cylinder, wherein the syringe pump is fluidly connected to the fluid reservoir tube, wherein the syringe pump is operable to draw cells from the cell source into the dosing tube assembly under negative pressure when the outlet end of the dosing tube is inserted into the cell source, and the syringe pump is further operable to pump cells contained in the dosing tube assembly into the implantable device under positive pressure when the outlet end of the dosing tube is inserted into the implantable device.

12. The cell loading system of claim 11 , further comprising means for adjusting the height of the dosing tube relative to the cell source and the implantable device.

13. The cell loading system claim 11 , wherein the implantable device comprises a device port, and wherein the dosing tube assembly comprises a fitting positioned between the device port and the dosing tube when the dosing tube is inserted into the device port.

14. The cell loading system of claim 9 , wherein:

the fluid reservoir tube has a first end fluidly connected to the dosing tube, a second end fluidly connected to the syringe pump, and a portion between the first and second ends that is wound into a coil; and

the cell loading system further comprises a mounting surface, wherein the coil is supported on the mounting surface in a horizontal position.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2025
From: GREEN, CHAD; MARTINSON, LAURA; OLSON, ERIK; BELLORA, VAL ANTHONY; ELLIOTT, LEAH; GRANT, RICHARD ALEXANDER; KOENIG, DONALD; STROLLO, GIACOMO
To: VIACYTE, INC.
Reel/Frame 072216/0775 →
Continuity (4)
Continuation 17551536 · Dec 15, 2021
Division 16912227 · Jun 25, 2020
Division 15528731
Related Publication 20230293812A1 · Sep 21, 2023
References Cited (39)
US 4242459A · Chick et al. · 1980 [cited by applicant]
US 5011472A · Aebischer et al. · 1991 [cited by applicant]
US 5158881A · Aebischer et al. · 1992 [cited by applicant]
US 5555920A · Godolphin et al. · 1996 [cited by applicant]
US 5837444A · Shah · 1998 [cited by applicant]
US 5976780A · Shah · 1999 [cited by applicant]
US 6599476B1 · Watson · 2003 [cited by examiner]
US 6617151B1 · Newman et al. · 2003 [cited by applicant]
US 6841129B2 · Braun · 2005 [cited by examiner]
US 7418981B2 · Baker et al. · 2008 [cited by applicant]
US 7723086B2 · Yu · 2010 [cited by examiner]
US 8096984B2 · Kucharczyk · 2012 [cited by examiner]
US 9033911B2 · de Juan, Jr. et al. · 2015 [cited by applicant]
US 9259526B2 · Barron et al. · 2016 [cited by applicant]
US 9433557B2 · Green · 2016 [cited by examiner]
US 9883987B2 · Lopez et al. · 2018 [cited by applicant]
US 10722644B2 · Green et al. · 2020 [cited by applicant]
US 11246979B2 · Green et al. · 2022 [cited by applicant]
US 20090081296A1 · Humes et al. · 2009 [cited by applicant]
US 20110067781A1 · Osborne · 2011 [cited by applicant]
US 20140014226A1 · Green et al. · 2014 [cited by applicant]
US 20150327875A1 · Look et al. · 2015 [cited by applicant]
EP 1174156A2 · 2002 [cited by applicant]
JP H06234164 · 1994 [cited by applicant]
JP 11506951 · 1999 [cited by applicant]
JP 2002515783A · 2002 [cited by applicant]
JP 2008023346 · 2008 [cited by applicant]
JP 3193534U · 2014 [cited by applicant]
WO WO1998002113 · 1998 [cited by applicant]
WO WO20150160348 · 2015 [cited by applicant]
WO WO20140173441A1 · 2024 [cited by applicant]
Vertex Pharmaceuticals Incorporated, “Vertex to acquire ViaCyte, with the goal of accelerating its potentially curative VX-880 programs in Type 1 Diabetes,” Press Release (Jul. 11, 2022) (2 pages). [cited by applicant]
International Search Report and Written Opinion dated Aug. 20, 2015, issued in connection with PCT/US2014/060306 (14 pages). [cited by applicant]
European Search Report dated Jun. 28, 2018, issued in connection with corresponding European Patent Application No. 14906271.3 (4 pages). [cited by applicant]
European Examination Report dated Jul. 10, 2018, issued in connection with corresponding European Patent Application No. 14906271.3 (8 pages). [cited by applicant]
Japanese Office Action dated Oct. 15, 2018, issued in connection with corresponding Japanese Patent App No. 2017-527636 (9 pages). [cited by applicant]
English translation of Japanese Office Action dated May 27, 2019, issued in connection with corresponding Japanese Patent App No. 2017-527636 (4 pages). [cited by applicant]
Extended European Search Report dated Feb. 22, 2022, issued in connection with corresponding European Patent Application No. 21204221.2 (9 pages). [cited by applicant]
English translation of Japanese Office Action dated Oct. 10, 2023, issued in connection with corresponding Japanese Patent App No. 2022-203617 (4 pages). [cited by applicant]